Consultation on a draft Global action plan to address ... · APOLLO SPECIALITY HOSPITAL 320 ANNA...
Transcript of Consultation on a draft Global action plan to address ... · APOLLO SPECIALITY HOSPITAL 320 ANNA...
Consultation on a draft Global action plan to address antimicrobial resistance
The questionnaire is divided into four sections. The questions are broadly framed and intended to
give you the opportunity to enter into some depth and explain your organization's viewpoint. While
only questions marked with * are mandatory, we would appreciate answers to as many as possible.
Where a choice of answer needs to be selected please highlight your answer.
Before answering the questions, please refer to our list of supporting documents.
http://www.who.int/drugresistance/amr-consultation/en/index.html
About you
1. Name of individual respondent*
(deleted)
2. Email address* (preference for official email addresses)
(deleted)
3. Are you authorised to represent your organization or interest group?* YES
4. Organization Name*
“Chennai declaration” initiative
5. Address of the organization*
APOLLO SPECIALITY HOSPITAL
320 ANNA SALAI, CHENNAI, INDIA 600035
6. Organization website (if available)
www.chennaideclaration.org
7. Country*
India
8. Type of Organization*
• Government department, ministry or agency
• Development or aid agency, foundation, trust or other funding authority
• International developmental organization
• Academic institution
• Civil society
• Private sector
• Other non-governmental organization (NGO)
• Other (please specify)
Position statement by representatives of various Medical societies in India
9. Main sector of interest
• Human health
• Animal health
• Finance/economics
• Agriculture or food
• Environment
• Communication, education and community
• Other (please specify)
10. Would you like to be added to our mailing list to receive updates on the development of the
global action plan?* YES
General questions
1. From the perspective of your organization, what are the most important areas of concern in
AMR?
Chennai declaration document is prepared by representatives of medical societies in India and
various other stakeholders. This is an Indian initiative, primarily aimed at tackling antibiotic
resistance in India and other developing countries.
Important areas of our concern are
1.No functioning antibiotic policies in most South Asian countries including India.
2. Very high antimicrobial resistance in South Asian countries
3. Unregulated OTC sale of antibiotics
4. Sanitation issues in the community
5.Antibiotic use in veterinary practice not regulated.
6. Inadequate awareness on resistance issues among health care professionals and general public
7.Inadequate infection control standards in Indian and other south Asian hospitals.
8.Inadequate training on infection control and antibiotic stewardship in the medical curriculum of
India and other South Asian countries.
2. Is your organization currently involved in work related to AMR? YES
If Yes, How?
Chennai declaration is the first ever joint recommendation by medical societies and other stakeholders in India, to tackle antibiotic resistance issue. Chennai declaration provided a practical and implementable solution to tackle antimicrobial resistance challenge; suitable to the background scenario of heterogeneity of health-care system in the country. Declaration recommendations are already studied in detail by Indian Ministry of Health. We are in constant touch with Ministry of Health officials on a daily basis. Ministry of Health has held multiple meetings to discuss Chennai declaration recommendations. Declaration recommendations have undoubtedly helped in speeding up the tackling resistance efforts by Indian Health ministry. Chennai declaration recommendations are discussed on a regular basis in meetings and conferences
of most medical societies in India. The document and the initiative created a serious attitude change
among Indian medical community. Medical societies became more open about the resistance issue.
Chennai declaration document has helped to create awareness among Indian public, as the details
and the progress of the recommendations are widely reported in Indian media.
Chennai Declaration recommendations are discussed in almost a dozen international medical
journals. Many reputed international medical conferences and policy meetings have discussed the
recommendations. This has helped in generating international opinion on the importance of tackling
resistance activities in developing countries.
Questions about the draft global action plan outline document
Before the WHA resolution was adopted, two WHO AMR Strategic Technical Advisory Group (STAG)
meetings were held in anticipation, which included members plus a large number of representatives
from other organizations. These meetings identified key issues, concerns and led to the
development of a draft outline.
As this consultation progresses and stakeholder meetings are held, the secretariat will harvest and
incorporate the input into the draft global action plan.
1. How would you rate your understanding of WHO’s intention in the development of a global
action plan to address AMR?
Very good__ Good__ Fair__ Poor__
Additional comments
WHO must take active interest in tackling antibiotics resistance activities by moving beyond an
advisory role , to the role of a real leader.
2. From the perspective of your organization, are the major issues relating to AMR outlined in
the draft global action plan? __ Y __
If No, what additional issues need to be addressed?
Most of the issue are mentioned. We must add the point that developed countries must help
developing world in stepping up infection control and laboratory facilities in developing countries.
Questions on the ‘Building blocks’ described in the draft outline.
You will notice, the global action plan has been constructed around “building blocks” in recognition
that different countries will have different starting points. In this situation, countries can choose
building blocks to concentrate upon. Each building block specified has been identified as a key area
where specific attention, planning and work are needed to achieve progress in addressing AMR.
Through questions in this section, we would like to hear your opinions on these building blocks in
more detail.
I. Building block-1: Increasing awareness and understanding about AMR and of the actions and
changes needed
a) What do you consider to be the main issues under this priority?
In developing world:
Health care professionals still lack understanding on the extent and the significance of antimicrobial
resistance problem.
Authorities in most developing countries not yet motivated to take initiatives to control resistance
menace.
Public not yet aware of the significance of the issue.
Media participation inadequate in most part of the developing world
b) What are the main actions that needs to be done -- and who are the main
actors/stakeholders who need to take action -- to go beyond the status quo?
WHO to take initiative to coordinate actions to convince authorities in developing countries
Chennai Declaration document and initiative in India made excellent progress in convincing medical
societies and authorities on the importance of the resistance issue. Indian Ministry of Health studied
the document in detail and the initiative played significant role in fast tracking the recent tackling
resistance initiatives by Ministry of Health and medical societies. All countries in developing world
should have similar initiatives. Chennai Declaration five- year plan is an ideal backbone for
implementation and formulation of strategies.
Authorities, medical societies, public, media and the health care industry are the main stakeholders.
c) What steps have already been taken to address this priority? (Please provide references
where possible)
1. In India representatives of medical societies, Health Ministry and other stakeholders organised a
meeting “A Road map to tackle the challenge of antimicrobial resistance”, the first ever meeting of
medical societies in India to discuss the resistance issue (August 2012)
The Chennai declaration document and initiative is as a result of this meeting.
Constant communication by Chennai declaration team with ministry of Health accelerated
publication of the modified OTC rule, initiation of preparation of the National antibiotics guideline
etc..
Chennai Declaration created a serious attitude change among Indian authorities, medical community
to a significant extent.
References
Ghafur A, Mathai D, Muruganathan A, et al. The Chennai declaration: a roadmap to tackle the
challenge of antimicrobial resistance. Indian J Cancer 2013; 50: 71–73.
http://www.indianjcancer.com/preprintarticle.asp?id=104065
Team C. "Chennai Declaration": 5-year plan to tackle the challenge of anti-microbial resistance.
Indian J Med Microbiol 2014;32:221-8.
http://www.ijmm.org/temp/IndianJMedMicrobiol323221-4847733_132757.pdf
Kanungo R. Endorsing Chennai declaration and implementing the strategy. Indian J Med Microbiol
2014;32:109
http://www.ijmm.org/temp/IndianJMedMicrobiol322109-4856297_132922.pdf
Goossens H. The Chennai declaration on antimicrobial resistance in India.Lancet Infect Dis 2013; 13:
105–06.
d) What are concrete and measurable indicators of progress for this priority? (Including, for
example, global and national goals to be achieved within 2, 5 and 10 years)
Chennai Declaration five year plan has explained these goals in detail. I have attached the document.
Team C. "Chennai Declaration": 5-year plan to tackle the challenge of anti-microbial resistance.
Indian J Med Microbiol 2014;32:221-8.
http://www.ijmm.org/temp/IndianJMedMicrobiol323221-4847733_132757.pdf
II. Building block-2: Identifying the most important approaches for preventing development of
infections and the steps needed to move beyond guidance to more effective implementation of such
approaches
a) What do you consider to be the main issues under this priority?
In developing countries lack of infrastructure to follow infection control precautions and guidelines is
the main impediment. Lack of awareness on the importance of the issue is also a major factor.
Sanitation issues in the community setting is an important risk
b) What are the main actions that needs to be done -- and who are the main
actors/stakeholders who need to take action -- to go beyond the status quo?
Basic facilities in hospitals in developing countries should be improved.
Governments in developing countries to devote more funds for this purpose
Developed world to help developing countries financially and technically to improve infection
control standards.
c) What significant work has already been done to address this? (Please provide references
where possible)
An attitude change (to acceptance of the problem) is the most important first step in tackling any
issue. In India Chennai Declaration initiative created this attitude change among Indian medical
societies and the authorities. This attitude change has resulted in multiple meetings at highest levels
in Indian Government to tackle the resistance issue. The results are already evident in the way Indian
authorities acknowledge the resistance issue and participate and collaborate in the tackling
resistance and infection control initiatives at national and international level.
d) What are concrete and measurable indicators of progress for this priority? (Including, for
example, global and national goals to be achieved within 2, 5 and 10 years)
Chennai Declaration five year plan has explained these goals in detail. I have attached the document.
Reference also provided.
III. Building block-3: Optimizing the use of existing antimicrobials for human and animal health
and in agriculture
a) What do you consider to be the main issues under this priority?
Lack of functioning antibiotics policies in most developing countries, to rationalise human and
veterinary antibiotic use.
Inadequate awareness on the importance of rational antibiotic use and resistance issue, in most
developing countries.
b) What are the main actions that needs to be done -- and who are the main
actors/stakeholders who need to take action -- to go beyond the status quo?
All developing countries must formulate an antibiotic policy and whole-heartedly take efforts to
implement it to the best of their ability.
A step –by- step strategy will be ideal for developing countries, starting with a liberal policy and then
made stricter once success of early stage is ensured. The new over the counter sale rule in India is
based on this strategy. Chennai declaration document has explained the strategy in detail.
c) What steps have already been taken to address this priority? (Please provide references
where possible)
India has already published a modified rule (H1 rule) to rationalise the OTC antibiotics sale. The
implementation is in early stage. Once succeeded, will provide the best strategic example to be
followed by all developing countries.
d) What are concrete and measurable indicators of progress for this priority? (Including, for
example, global and national goals to be achieved within 2, 5 and 10 years)
Chennai Declaration five year plan has explained this in detail. Document and reference attached.
IV. Building block-4: Identifying and closing critical gaps in knowledge needed to address AMR
a) What do you consider to be the main issues under this priority?
Most developing countries do not have nationwide surveillance system and hence do not know the
real extent of the problem.
b) What are the main actions that needs to be done -- and who are the main
actors/stakeholders who need to take action -- to go beyond the status quo?
1. Health ministries of all developing countries must take initiatives to establish a national
surveillance system
2. WHO should be the agency the coordinating various national networks, developing a global
network.
c) What steps have already been taken to address this priority? (Please provide references
where possible)
Some developing countries have networks but mostly inadequate.
d) What are concrete and measurable indicators of progress for this priority? (Including, for
example, global and national goals to be achieved within 2, 5 and 10 years)
Chennai declaration five year plan attached.
V. Building block-5: Developing an innovative and sustainable approach to develop and
distribute critical products and technologies needed to address AMR
a) What do you consider to be the main issues under this priority?
Lack of enough research to develop new antibiotics, especially ones against Gram negatives.
The only immediate solution to the resistance problem is development of new antibiotics.
b) What are the main actions that needs to be done -- and who are the main
actors/stakeholders who need to take action -- to go beyond the status quo?
Enhancing research to develop new antibiotics. Pharmaceutical industry and Governments
c) What steps have already been taken to address this priority? (please provide references
where possible)
There have been efforts to address the issue, but needs more momentum at international and
regional level
d) What are concrete and measurable indicators of progress for this priority? (Including, for
example, global and national goals to be achieved within 2, 5 and 10 years)
Strategy for developing countries explained in Chennai declaration five year plan
VI. Building block-6: Assessing the long term economic, developmental and social costs and
implications of AMR as a basis for sustainable investment and action
a) What do you consider to be the main issues under this priority?
Inadequate investment by Governments on tackling resistance issue
b) What are the main actions that needs to be done -- and who are the main
actors/stakeholders who need to take action -- to go beyond the status quo?
1. Investment to improve sanitation issues in developing countries.
2.Investment in improving infection control standards in hospitals
3. Investment to improve laboratory network in developing countries.
c) What steps have already been taken to address this priority? (please provide references
where possible)
Indian Govt. has announced a master plan to improve sanitation in Indian cities.
Indian health ministry has decided to expand vaccination coverage
Indian Health Ministry has allotted funds to tackle antibiotics resistance.
d) What are concrete and measurable indicators of progress for this priority? (Including, for
example, global and national goals to be achieved within 2, 5 and 10 years)
Explained in Chennai declaration five year plan-attached.
Concluding questions
3. What contribution would your organization be able to make in implementing the global
action plan?
1. Will communicate and motivate Indian Health Ministry to implement the recommendations
2. Will motivate all stakeholders to cooperate in implementing the recommendations.
4. Additional input that you feel would be facilitate development of the GAP.
We already have plenty of well-intentioned documents to tackle the resistance, prepared by various
organisations.
What the world needs is real action.
Reproduced with kind permission of “Chennai Declaration five year plan team” and Indian
Journal of Medical Microbiology(IJMM)
Team C. "Chennai Declaration": 5-year plan to tackle the challenge of anti-microbial resistance.
Indian J Med Microbiol 2014;32:221-8.
http://www.ijmm.org/temp/IndianJMedMicrobiol323221-4847733_132757.pdf
Chennai Declaration Implementation-Five Year Plan
The “Chennai declaration-five year plan” is designed as a companion document to the original
“Chennai declaration”.1Details on various components of the five-year plan are already
elucidated in the declaration document. The proposal provides a time bound action plan to
various recommendations of the declaration. Readers are encouraged to refer to “The Chennai
declaration” document for details.
STRATEGY ONE YEAR TWO YEAR FIVE YEAR
OVER THE COUNTER SALE OF
ANTIBIOTICS (SCHEDULEH1 )13
Coordinator: DCGI/State Drug
Controller
24 antibiotics
included in the
Restricted list (as
per the modified
H1 list published by
MOH)
60% of all antibiotics
to be included in the
restricted list
90% of all to be
included antibiotics
in the restricted list
IN-HOSPITAL ANTIBIOTIC
MONITORING (STRATEGY AS PER
THE CHENNAI DECLARATION
RECOMMENDATION1)
Coordinator: Hospital infection
control committee
Collaborator: State ICC, National
Task Force, Hospital
accreditation agencies
ANTIBIOTIC POLICY
All tertiary
care***hospitals to
have an antibiotic
policy.
All secondary care**
and primary care*
facilities to have an
antibiotic policy.
HIGH END ANTIBIOTIC MONITORING
Initiatives to
implement the
strategy1 in all
tertiary
carehospitals.(App
endix 1&2)
All tertiary care
hospitals following the
strategy.
Initiatives to
implement the
strategy in all
secondary care
hospitals.
All hospitals
following the
strategy.
ANTIBIOTIC STEWARD1
Second opinion on
high end antibiotic
usage by an antibiotic
steward available in all
tertiary care hospitals.
Second opinion by
an antibiotic steward
available in
secondary care
hospitals.
SURGICAL ANTIBIOTIC PROPHYLAXIS MONITORING
SHEET(APPENDIX 3)
Surgical antibiotic
prophylaxis
monitoring sheet
to be used in all
tertiary care
hospitals
Surgical antibiotic
prophylaxis
monitoring sheet to be
used in all secondary
care* hospitals
Surgical antibiotic
prophylaxis
monitoring sheet to
be used in all
primary* hospitals
AN AUTONOMOUS ANTIBIOTIC
POLICY ACCREDITATION AGENCY
(APAA)
(May be within NABH or as an
independent body) should be
constituted by State/Centre and
all hospitals mandated to apply
for accreditation it at a nominal
fees.
Insurance/Corporate and third
party payers encouraged to send
their clients only to hospitals
accredited with such a policy.
Initiatives to set up
APPA
All major tertiary care
hospitals APAA
accredited.
Initiatives to get
secondary care
hospitals APPA
accredited.
All primary and
secondary care
hospitals APAA
accredited.
STEPPING UP INFECTION
CONTROL FACILITIES IN
HOSPITALS
Coordinator: Hospital Infection
control committee
Collaborator: State ICC, Central
task force, Hospital accreditation
National task force
formed.
State infection control
committees and
District task forcesset
up
All tertiary and
secondary care
hospitals to have
infection control
Primary care hospitals
to have infection
control teams.
agencies.
teams.
Use of alcohol
hand rub in all
tertiary care
facilities
Alcohol hand rubs to
be used in all
secondary and
primary care facilities.
Measures to
increase compliance
to hand hygiene
techniques in all
health care facilities
Isolation precautions
strictly followed, in
practice, in all tertiary
care facilities, to the
best of their ability.
Isolation precautions
to be followed in
practice, based on
the available
infrastructure, to the
best of their ability,
in all health care
facilities.
NATIONAL ADVISORY BOARD
(DOH/NCDC) TO PREPARE
GUIDELINES FOR INFECTION
PREVENTIONAND
ANTIMICROBIAL STEWARDSHIP
IN INDIA
Coordinator: Directorate General
of Health Services/National
Centre for Disease Control
(DGHS/NCDC)
Collaborator: Medical Societies
Guideline
committee to
initiate formulation
of national
guidelines.
Guideline committee
to publish national
guidelines.
Guideline committee
to modify
recommendations
basedon prevailing
resistance scenario
and the success of
various tackling
resistance efforts.
RATIONALISING ANTIBIOTIC
USAGE IN VETERINARY PRACTICE
Coordinator: State Animal
Husbandry Department and State
Drug Controller
REGULATION OF ANTIBIOTIC USAGE IN VETERINARY PRACTICES
Antibiotics used in
human treatment
to be banned as
growth promoters
in food animals
To regulate
prophylactic and
metaphylactic usage
of antibiotics in
veterinary practice.
All veterinary
antibiotics should
need prescription.
Coordinator: State Animal OVER THE COUNTER SALE OF ANTIBIOTICS FOR ANIMAL USE
Husbandry Department and State
Drug Controller
Efforts to formulate regulations to rationalize OTC sale of antibiotics for animal use
Initiation of implementation of the rule.Sale of antibiotics only on the prescription slips of the veterinarians under their registered license number. Restriction on sale of antibiotics to dairy farmers and unauthorized veterinary workers
Efforts to increase
compliance to the
policy
Coordinator: State Animal Husbandry Department Collaborator: State
Agricultural/Veterinary
Universities and ICAR(Indian
Council of Agricultural Research)
and ICMR(Indian Council of
Medical research)
NATIONAL ANTIBIOTIC RESISTANCE MONITORING NETWORK.
At district level
Veterinary
Hospitals to
participate in the
network, prepare
data base of
antibiotic
resistance
About 5 Veterinary
Hospitals in each
district participating in
the network
About 10-15
Veterinary Hospitals
in each district
participating in the
network
SETTING UP OF FACILITIES FOR ANTIBIOTIC SENSITIVITY TESTING
OF MASTITIS AND CLINICAL SAMPLES FROM ANIMALS
District level Tehsil level Block level
MONITORING OF ANTIBIOTIC RESIDUES IN FOOD OF ANIMAL ORIGIN.
National task force
formed
State level task force
formed
District level task
force
Coordinator: State animal Husbandry Department Collaborator: ICAR and State Agricultural/veterinary Universities
STRICT COMPLIANCE FOR OBSERVANCE OF THE ANTIBIOTIC WITHDRAWAL PERIOD FOR FOOD ANIMALS.
State level
monitoring system
Divisional level
monitoring system
District level
monitoring system
CLINICAL RESEARCH TO EXPLORE
EXISTING OPTIONS TO TREAT
INFECTIONS DUE TO MDR GRAM
NEGATIVE BACTERIA
Coordinator: ICMR
Multicentre clinical
studies on
combination
therapy against
MDR Gram
negative infections
initiated.
Preventive strategies, including decolonization trials
Results of the large
multicenter trials
published. Clinicians
able to choose the
best combination
against these bacteria
Need community based studies on the prevalence of MDR bacteria
India to be making a
significant
contribution to
academic world
knowledge on
treatment of MDR
bacterial infections.
Implementation of
protocol studies
MEDICAL COUNCIL OF INDIA AND
CURRICULUM CHANGES
Coordinator:MCI(Medical council
of India)
Collaborator:DME(Directorate of
Medical Education)
Initiating
discussions on
necessary
curriculum changes
to encourage
rational antibiotic
usage and infection
control (for
doctors, nurses and
pharmacists)
MCI/National
Board to take
initiative towards
DM/DNB training in
ID
New modules
introduced into all
medical schools.
Discussions on
extensive curriculum
changes initiated.
Post-doctoral training
in Infectious diseases
(DM/DNB) started in
at least 10 medical
schools
Modified curriculum
introduced into all
medical schools.
At least 50 medical
schools starting
infectious disease
training
NATIONAL ANTIBIOTIC
RESISTANCE MONITORING
NETWORK
Coordinator: NCDC/ICMR
Collaborator: NCDC/ICMR, state
DOH
10-25 hospitals
from each state
participating in the
network
50 hospitals from each
state in the network
100 hospitals from
each state in the
network
NCDC /ICMR
functioning as the
national reference
laboratory for
antibiotic
resistance studies
Data available on
molecular
epidemiology of MDR
bacteria especially
Gram-negatives.
Extensive nationwide
data available on
molecular
epidemiology of
MDR Gram-positive
and -negative
bacteria.
ENCOURAGE RESEARCH TO
DEVELOP NEW MOLECULES
Coordinator: Council of Scientific
and Industrial Research(CSIR)
Collaborator:ICMR,Pharmaceutic
al industry
ANTIBIOTICS
Discussion with
pharma industry to
identify molecules
already in
development and
encourage the
progression of
promising leads
Public private
partnership to develop
new molecules
explored
Fast tracking of
promising antibiotics
especially those active
against MDR Gram-
negative bacteria
VACCINES
Encourage research to
develop new vaccines
Promising vaccines
identified and
options to enhance
further research
explored
ACTIVE CONTRIBUTION OF
MEDICAL SOCIETIES
POSITION STATEMENT FROM ALL
MAJOR SOCIETIES TOWARDS
INFECTION CONTROL AND
ANTIBIOTIC STEWARDSHIP
CONTINUING MEDICAL EDUCATION(CME)
All medical
societies
conducting CMEs
on antibiotic
stewardship and
infection control
(supervised by a
neutral scientific
committee)
through their local
branches-(25% of
local branches
coverage
CME-50% coverage
CME-100% coverage
ACTIVE PARTICIPATION IN ANTIBIOTIC AWARENESS WEEK
ACTIVITIES
Active participation
of half of all major
societies
Active participation of
2/3rdof all major
societies
All major societies
active and regular
participation
INTRODUCTION OF ONLINE
MODULES ON ANTIBIOTIC
USAGE.
(Developed by National
Antibiotic Guideline committee)
5000 doctors
completing the
module
50000 doctors
completing the
module.
All registered
medical practitioners
completing the
module.
MEDICAL JOURNALS To publish
editorials on
tackling resistance-
in all major journals
At least one article on
the subject in every
issue of the journal
Indian journals to
have a leading role in
publishing papers on
antibiotic resistance
ROLE OF MEDIA MOH to issue
advertisements in
visual and print
media on rational
antibiotic usage,
directed at
practitioners and
public.
Active media
participation in
Antibiotic
Awareness Week.
Frequent articles and
programmes on the
subject in the media
NGO (NON -GOVERNMENTAL
ORGANISATIONS)
MOH and medical
societies initiating
discussion with
NGOs seeking
participation in
tackling antibiotics
resistance
activities.
Nationwide
activities. Message
reaching Indian
villages
Awareness
activities in schools
and colleges, clubs
etc...in metros.
Awareness activities in
schools and colleges,
clubs etc. in cities
MEASURES TO IMPROVE Seek advice from
experts in relevant
Pilot schemes in Nationwide
implementation of
SANITATION
Coordinator: Ministry of Drinking
Water and Sanitation(Ministry of
Rural Development)/Ministry of
Urban Development
Collaborator: State Water
Boards
areas of public
health, and various
branches of
science.
Practical and
implementable
strategies
identified.
selected locations successful strategies.
HOSPITAL ACCREDITATION
AGENCIES (NABH, ISO ETC.) ROLE
Strict monitoring
on compliance to
the infection
control and
antibiotic policy,
during
accreditation and
reaccreditation
process.
NABH sending
good practices
advisory to all
hospitals on
antibiotic
stewardship and
infection control
Conducting national
antibiotic stewardship
programmes for all
doctors (nationwide)
Capacity building for
infection control
nursing staff (nation
wide)
Sustaining
standardized
surveillance methods
Establishing
National, State Data
collection and
management and
designing policies
accordingly
*Primary care centers: Hospitals with fewer than 100 beds and no NABL-accredited
microbiology laboratory.
** Secondary care centers: Hospitals with fewer than 500 beds, not having an NABL-
accredited laboratory
***Tertiary care centers: Hospitals with more than 500 beds or hospital of any bed strength
with an NABL-accredited laboratory
STEPPING UP MICROBIOLOGY
LAB FACILITIES ACROSS THE
COUNTRY
Tertiary care
hospital labs
should be able to
perform culture
from all kinds of
samples.
Secondary care
hospitals should be
able to perform
culture of all kinds
of samples. If
unable to process,
outsourcing of
samples is an
option
All secondary care
hospital labs able to
perform culture and
susceptibility testing
of all samples using
standardized
methodology(as per
ICMR surveillance
network
recommendation)
Primary care facilities
able to perform Gram
stain and AFB stains.
All tertiary acre and
secondary care
hospitals in the
country following
standardized
methodology to
perform cultures and
susceptibility testing
of all samples.
COMPUTERISATION.
SOFTWARE BASED PROGRAMME:
Eg: WHONET
All tertiary care
hospitals using
WHONET software
All secondary care
hospitals using the
software
Nationwide data
available via online
data entry in a
designated website